153 related articles for article (PubMed ID: 7548274)
21. Upregulation of DF3, in association with ICAM-1 and MHC class II by IFN-gamma in short-term human mammary carcinoma cell cultures.
Sgagias MK; Nieroda C; Yannelli JR; Cowan KH; Danforth DN
Cancer Biother Radiopharm; 1996 Jun; 11(3):177-85. PubMed ID: 10851535
[TBL] [Abstract][Full Text] [Related]
22. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
[TBL] [Abstract][Full Text] [Related]
23. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs.
Lim YS; Kang BY; Kim EJ; Kim SH; Hwang SY; Kim TS
Mol Cells; 1998 Oct; 8(5):629-36. PubMed ID: 9856353
[TBL] [Abstract][Full Text] [Related]
24. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
[TBL] [Abstract][Full Text] [Related]
25. Systemic effects of cytokines released by gene-transduced tumor cells: marked hyperplasia induced in small bowel by gamma-interferon transfectants through host lymphocytes.
Lollini PL; D'Errico A; De Giovanni C; Landuzzi L; Frabetti F; Nicoletti G; Cavallo F; Giovarelli M; Grigioni WF; Nanni P
Int J Cancer; 1995 May; 61(3):425-30. PubMed ID: 7729957
[TBL] [Abstract][Full Text] [Related]
26. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
[TBL] [Abstract][Full Text] [Related]
27. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
[TBL] [Abstract][Full Text] [Related]
28. [A novel experimental approach to immunotherapy against malignant brain tumor with the mouse IFN-gamma gene transfer].
Nishihara K
Nihon Geka Hokan; 1989 Jan; 58(1):18-42. PubMed ID: 2508589
[TBL] [Abstract][Full Text] [Related]
29. Expression of a transfected H-2Kb gene in B16 cells correlates with suppression of liver metastases in triple immunodeficient mice.
Calorini L; Marozzi A; Byers HR; Waneck GL; Lee KW; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1992 Jul; 52(14):4036-41. PubMed ID: 1617680
[TBL] [Abstract][Full Text] [Related]
30. H-2Kb and H-2Db gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules.
De Giovanni C; Nicoletti G; Sensi M; Santoni A; Palmieri G; Landuzzi L; Nanni P; Lollini PL
Int J Cancer; 1994 Oct; 59(2):269-74. PubMed ID: 7927928
[TBL] [Abstract][Full Text] [Related]
31. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
32. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
duPre' SA; Redelman D; Hunter KW
Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
[TBL] [Abstract][Full Text] [Related]
34. B7-1, IFN gamma and anti-CTLA-4 co-operate to prevent T-cell tolerization during immunotherapy against a murine T-lymphoma.
Van Ginderachter JA; Liu Y; Geldhof AB; Brijs L; Thielemans K; De Baetselier P; Raes G
Int J Cancer; 2000 Aug; 87(4):539-47. PubMed ID: 10918195
[TBL] [Abstract][Full Text] [Related]
35. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
[TBL] [Abstract][Full Text] [Related]
36. Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.
Panelli MC; Wang E; Shen S; Schluter SF; Bernstein RM; Hersh EM; Stopeck A; Gangavalli R; Barber J; Jolly D; Akporiaye ET
Cancer Immunol Immunother; 1996 Feb; 42(2):99-107. PubMed ID: 8620527
[TBL] [Abstract][Full Text] [Related]
37. Immunization by gamma-IFN-treated B16-F10.9 melanoma cells protects against metastatic spread of the parental tumor.
Porgador A; Brenner B; Vadai E; Feldman M; Eisenbach L
Int J Cancer Suppl; 1991; 6():54-60. PubMed ID: 1906054
[TBL] [Abstract][Full Text] [Related]
38. Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes.
Musiani P; Modesti A; Brunetti M; Modica A; Vitullo P; Gulino A; Bosco MC; Colombo MP; Nanni P; Cavallo F
Nat Immun; 1994; 13(2-3):93-101. PubMed ID: 8173240
[TBL] [Abstract][Full Text] [Related]
39. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
40. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
Kyprianou N; Isaacs JT
Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]